NCT00188604View on ClinicalTrials.gov

The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Breast NeoplasmsLymphedema
Interventions
DRUG

sodium selenite

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00188604 - The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer | Biotech Hunter | Biotech Hunter